Preview Mode Links will not work in preview mode

GRACEcast

Dec 27, 2012

Dr. Jack West describes his evolving perspective on the yield of testing for molecular markers, which is leading him to become more optimistic about testing a broader range of people with NSCLC.


Dec 27, 2012

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.


Dec 27, 2012

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.


Dec 25, 2012

Dr. Jack West wishes the cancer community a happy holiday season from GRACE.


Dec 19, 2012

Dr. Jack West describes a potentially efficient way to improve delivery of increasingly specialized care to broad geographic areas by collaboration of healthcare network teams using telemedicine solutions currently available.